01 6LA JOLLA PHARMA
01 610500247
01 6Blank
01 6Blank
01 62029-12-16
Patent Expiration Date : 2029-12-16
US Patent Number : 10500247
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2681
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-16
Patent Expiration Date : 2029-12-16
US Patent Number : 10500247
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2680
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-16
Patent Expiration Date : 2029-12-16
US Patent Number : 10500247
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2680
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-16
Patent Expiration Date : 2029-12-16
US Patent Number : 10500247
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2681
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-16
Patent Expiration Date : 2029-12-16
US Patent Number : 10500247
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2681
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-16
Patent Expiration Date : 2029-12-16
US Patent Number : 10500247
Drug Substance Claim :
Drug Product Claim :
Application Number : 209360
Patent Use Code : U-2680
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-16
